亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial

医学 丛集性头痛 安慰剂 整群随机对照试验 随机对照试验 双盲 麻醉 外科 偏头痛 替代医学 病理
作者
Élizabeth Leroux,Dominique Valade,Irina Taifas,Éric Vicaut,Miguel Chagnon,Caroline Roos,Anne Ducros
出处
期刊:Lancet Neurology [Elsevier BV]
卷期号:10 (10): 891-897 被引量:210
标识
DOI:10.1016/s1474-4422(11)70186-7
摘要

Suboccipital steroid injections can be used for preventive treatment of cluster headache but few data are available for the efficacy of this approach in clinical trials. We aimed to assess efficacy and safety of repeated suboccipital injections with cortivazol compared with placebo as add-on therapy in patients having frequent daily attacks.In our randomised, double-blind, placebo-controlled trial at the Emergency Headache Centre in Paris, France, we enrolled adults aged 18-65 years with more than two cluster headache attacks per day. We randomly allocated patients to receive three suboccipital injections (48-72 h apart) of cortivazol 3·75 mg or placebo, as add-on treatment to oral verapamil in patients with episodic cluster headache and as add-on prophylaxis for those with chronic cluster headache, on the basis of a computer-generated list (blocks of four for each stratum). Injections were done by physicians who were aware of treatment allocation, but patients and the evaluating physician were masked to allocation. The primary outcome was reduction of the number of daily attacks to a mean of two or fewer in the 72 h period 2-4 days after the third injection. We assessed all patients who received at least one dose of study drug in the intention-to-treat analysis. This study is registered with ClinicalTrials.gov, number NCT00804895.Between November, 2008, and July, 2009, we randomly allocated 43 patients (15 with chronic and 28 with episodic cluster headache) to receive cortivazol or placebo. 20 of 21 patients who received cortivazol had a mean of two or fewer daily attacks after injections compared with 12 of 22 controls (odds ratio 14·5, 95% CI 1·8-116·9; p=0·012). Patients who received cortivazol also had fewer attacks (mean 10·6, 95% CI 1·4-19·9) in the first 15 days of study than did controls (30·3, 21·4-39·3; mean difference 19·7, 6·8-32·6; p=0·004). We noted no serious adverse events, and 32 (74%) of 43 patients had other adverse events (18 of 21 patients who received cortivazol and 14 of 22 controls; p=0·162); the most common adverse events were injection-site neck pain and non-cluster headache.Suboccipital cortivazol injections can relieve cluster headaches rapidly in patients having frequent daily attacks, irrespective of type (chronic or episodic). Safety and tolerability need to be confirmed in larger studies.None.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
8秒前
agathahqs的应助被纯情的阁采纳,获得30
13秒前
agathahqs的应助被纯情的阁采纳,获得10
13秒前
agathahqs的应助被纯情的阁采纳,获得10
13秒前
agathahqs的应助被纯情的阁采纳,获得10
13秒前
null的应助被纯情的阁采纳,获得10
13秒前
null的应助被纯情的阁采纳,获得10
14秒前
奔跑的应助被纯情的阁采纳,获得10
14秒前
17秒前
冷傲的中恶完成签到,获得积分10
30秒前
敏感兰完成签到,获得积分10
38秒前
double_sweet完成签到,获得积分10
41秒前
Benhnhk21完成签到,获得积分10
46秒前
49秒前
null的应助被科研通管家采纳,获得10
52秒前
顾矜的应助被纯情的阁采纳,获得10
53秒前
完美的飞兰完成签到,获得积分10
59秒前
59秒前
纯情的阁发布了新的文献求助10
1分钟前
暴躁的尔柳完成签到,获得积分10
1分钟前
1分钟前
阔达之卉完成签到 ,获得积分10
1分钟前
欢喜的小蕾完成签到,获得积分10
1分钟前
纯情的阁发布了新的文献求助10
1分钟前
2分钟前
忧郁血茗完成签到,获得积分10
2分钟前
2分钟前
2分钟前
丰富的雅绿完成签到,获得积分10
2分钟前
2分钟前
帅气寄风完成签到,获得积分10
2分钟前
2分钟前
2分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
3分钟前
3分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
3分钟前
bkagyin的应助被纯情的阁采纳,获得10
3分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
3分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
3分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158827
求助须知:如何正确求助?哪些是违规求助? 9554476
关于积分的说明 21719316
捐赠科研通 7748395
什么是DOI,文献DOI怎么找? 3427099
关于科研通互助平台的介绍 2552000
邀请新用户注册赠送积分活动 2471370